Equillium reports $40.9M cash prelim as of Dec 31, 2023; upsizes ATM to $21.95M

Equillium, Inc.

Preliminary cash, equivalents & short-term investments of $40.9M as of Dec 31, 2023 (unaudited).
Filed prospectus supplement to offer up to $21.95M of common stock via ATM with Jefferies (prior capacity $6.34M).
No shares sold under the ATM to date; upsized capacity signals potential future dilution.
Actual Q4 2023 financial statements not yet available; amounts subject to final closing adjustments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.